glp-1 marketing Drug Market: the rapid growth of the diabetes and obesity drugs market GLP-1 Receptor Agonist Market Size

The brand positions it as a "gut-first" alternative to injectable GLP-1 drugs like semaglutide and tirzepatide: something you can buy without a prescription, take orally, and use as a lower-cost, lower-commitment starting point

Kulkarni, A., Dangat, K., Kale, A., Sable, P., Chavan-Gautam, P

On the evening of 20 March 2026, hours before Novo Nordisks Indian patent on semaglutide formally expired, Natco Pharma announced that its generic vial would sell for 1,290 a month

By implementing smart dietary choices opting for smaller, more frequent meals, prioritizing bland and low-fat foods, and ensuring adequate hydration you can significantly mitigate discomfort

Nikhil R

Glutathione peroxidase 4 (GPX4) and obesity interact to impact tumor progression and treatment response in triple negative breast cancer